Spectrum: Autism Research News
Much of Benjamin Philpot’s work focuses on trying to determine the synaptic basis of Angelman syndrome and autism, as well investigating how synaptic plasticity is controlled.
On 25 September, Benjamin Philpot discussed his work investigating compounds to treat Angelman syndrome. He presented data on a pharmacological agent that activates a gene silenced in those with the disorder. Philpot is associate professor of cell and molecular physiology at the University of North Carolina School of Medicine in Chapel Hill.
You can watch a complete replay of the webinar above.
Use the comments section below to submit questions we didn’t have time to discuss during the Q&A session, or to pose follow-up questions for Philpot.